This Week in Psychedelics

A New York lawmaker introduced a bill to legalize psilocybin for medical purposes, and three Canadians get permission to use psilocybin.

December 17, 2021

This Week...

A New York lawmaker introduced a bill to legalize psilocybin mushrooms for medical purposes and establish facilities where the psychedelic could be grown and administered to patients. Here’s more:

Despite having to wait 283 days for a decision, three Canadians suffering from mental health conditions were given permission by the government to use psilocybin mushrooms to treat those conditions.  While it’s absurd to need permission from the government for such a thing, this is the first time we’ve seen the government make exceptions regarding waivers for psilocybin-assisted therapy to treat anxiety, depression, addiction, and chronic pain. Here’s more:

Since the turn of the century, more than 325 clinical trials with psychedelic medicines have taken place globally. And a recent survey revealed the vast majority of health workers believe psychedelics can provide therapeutic benefit to users in a medical setting, with 70% supporting the easing of restrictions to facilitate greater research.  You can read more about that survey here:

Did You Know?

Did you know that DMT is a chemical compound that already exists in the human body, thereby indicating that we already have receptors that exist specifically to process the drug?  Some research even suggests that our brains naturally release DMT during death, birth, and even orgasm.